BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 9, 2013
View Archived Issues
The identification of a novel target for the treatment of obesity-related endothelial dysfunction
Read More
Addex shows preclinical proof of concept for ADX-71441 in Charcot-Marie-Tooth 1A disease
Read More
New proteins binding to human ubiquitin designed by Scil Proteins
Read More
New gene therapy vectors for adrenoleukodystrophy
Read More
Autifony Therapeutics synthesizes new voltage-gated potassium channel modulators
Read More
Stemline's SL-401 produces complete response in BPDCN
Read More
Novel NS3/NS4A inhibitors disclosed by Bristol-Myers Squibb
Read More
Rib-X Pharmaceuticals synthesizes new antibacterial agents
Read More
Researchers at CSL disclose new G-CSF-R antibodies
Read More
HOXC10 gene implicated in response to breast cancer chemotherapy
Read More
AstraZeneca synthesizes promising DGAT1 inhibitor
Read More
ChemoCentryx's CCR9 inhibitor CCX-507 enters clinical trials
Read More
Orexigen Therapeutics progresses with FDA on resubmission of Contrave NDA
Read More
FDA grants orphan drug status to novel terlipressin formulation for treatment of ascites
Read More
XOMA reports topline data from study of gevokizumab in acne vulgaris
Read More
Pivotal ESTEEM trials of apremilast in psoriasis meet key endpoints
Read More
Gliadel Implant launched in Japan
Read More
Alkermes reports topline results from phase I study of novel combination treatment for schizophrenia
Read More
Vaccinex begins phase I trial of VX-15/2503 in multiple sclerosis
Read More
Study identifies gene linked to breast cancer liver metastases
Read More
European Commission approves expanded indication for Prevenar 13 vaccine
Read More
Merus selects lead candidate for AML
Read More
Ariad and U.K.'s NCRI to collaborate on phase III ponatinib trial
Read More
Galapagos delivers fifth drug candidate to GSK under disease-modifying drug alliance
Read More
Krystexxa approved in E.U. for certain patients with chronic tophaceous gout
Read More
GVHD studied in canine model of in utero hematopoietic cell transplantation
Read More